InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Tech-clone post# 204956

Saturday, 02/07/2015 7:42:13 PM

Saturday, February 07, 2015 7:42:13 PM

Post# of 346050
Tech-clone, nice to hear you are able to make this presentation in person. It looks like this event has garnered lots of attention because now its available as a webcast for anyone that can't make it in person.

I'd still prefer to make it in person though, because Peregrine KOL's David Carbone (2015 President of IASLC) and Scott Antonia have spent their entire professional careers searching for the best treatments for lung cancer and both are backing Bavituximab, PS Targeting and must be for a very good reason.

Below are the details from the website and notice the red highlight => now available on webcast

Lots happening in March and not sure if anything happens but we have earnings and who knows, if anything of material happens before March 7th 2015... it only gives reason why this event now is being webcast.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110599254

------------------------------------------

Tampa HOPE Summit

A survivorship conference for anyone who has ever been
diagnosed with lung cancer

Saturday, March 7, 2015

While lung cancer survivors are encouraged and invited to attend, caregivers and medical professionals wanting to learn more about lung cancer survivorship are also welcome to register to attend. All conference sessions will be geared toward those who have been diagnosed with lung cancer.
LOCATION

Moffitt Cancer Center
Vincent A. Stabile Research Building, Ted and Marty Couch Auditorium
12902 Magnolia Drive
Tampa, FL 33612

REGISTER NOW

OR
Attend by webinar! Register to attend online via Zoom.


ABOUT THIS EVENT

On Saturday, March 7, in Tampa, Florida, LUNGevity is partnering with Patient Power for HOPE Summit Live! — a free in-person forum at Moffitt Cancer Center, where you and your loved one can hear the latest in treatment and research from leading lung cancer experts. Hear about emerging therapies, understand current treatment options, and learn about support resources.

During this interactive summit, you will have the opportunity to meet and to connect with experts, other patients, survivors, and caregivers touched by lung cancer. Our hope is that you’ll share your knowledge with your peers, learn, and become inspired!

Please join us in person for this FREE interactive summit to learn:

Explaining lung cancer today
What do we know and what do we do about it?
Where are we headed and how quickly?
How is this personalized to you? What does this mean to you?

Patient, caregiver, nurse, and social worker perspective: how to live well

Tips and resources
How and when to get support
Financial, social, and logistical information

Our expert panel will take your submitted questions, and advocates will be on hand to offer support and to connect with a broad range of resources.
Guest Presenters

David Carbone, MD, PhD
Director, James Thoracic Center, James Cancer Hospital and Solove Research Institute

Scott J. Antonia, MD, PhD
Program Leader, Thoracic Oncolocy, Moffitt Cancer Center

Sponsors

This in-person forum is sponsored by the Patient Empowerment Network through educational grants from Pfizer, Genentech, and Novartis, with additional funding from LUNGevity.

http://lungevity.donordrive.com/index.cfm?fuseaction=donorDrive.event&eventID=532



-----------------------------------------------------------

Now digging deeper:

1) Check out the Scientific Advisory Board of LUNGevity and notice David Carbone is here and remember, David Carbone out of all these global leaders... was chosen to lead, as President.. IASLC

http://lungevity.org/about-us/our-people/scientific-advisory-board

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=106237896

https://www.iaslc.org/about-us/board


2) Lots of names on the survivor stories... if any connect to other dots then I'll report back but Peregrine followers are building quick and naturally, any survivors/family members will be the first to start following the company that gives hope to family/friends/relatives..etc

http://lungevity.org/support-survivorship/survivor-resource-center/survivor-stories


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News